Cargando…

Is Bayh-Dole Good for Developing Countries? Lessons from the US Experience

The US Bayh-Dole Act encourages university patenting of inventions arising from publicly funded research. Lessons from three decades of US experience serve as a cautionary tale for those countries that may choose to emulate Bayh-Dole.

Detalles Bibliográficos
Autores principales:	So, Anthony D, Sampat, Bhaven N, Rai, Arti K, Cook-Deegan, Robert, Reichman, Jerome H, Weissman, Robert, Kapczynski, Amy
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2008
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2573936/ https://www.ncbi.nlm.nih.gov/pubmed/18959484 http://dx.doi.org/10.1371/journal.pbio.0060262

Ejemplares similares

The Stakes in Bayh-Dole: Public Values Beyond the Pace of Innovation
por: Valdivia, Walter D.
Publicado: (2011)

COVID-IP: staring down the Bayh–Dole Act with 2020 vision
por: Paradise, Jordan
Publicado: (2020)

NIH funding for patents that contribute to market exclusivity of drugs approved 2010–2019 and the public interest protections of Bayh-Dole
por: Ledley, Fred D., et al.
Publicado: (2023)

Accountability in patenting of federally funded research
por: Rai, Arti, et al.
Publicado: (2012)

A Doleful Picture
Publicado: (1888)

Polymorphs and Prodrugs and Salts (Oh My!): An Empirical Analysis of “Secondary” Pharmaceutical Patents
por: Kapczynski, Amy, et al.
Publicado: (2012)

Effect of Unemployment and the Dole on the Health and Habit of the Nation
por: Nethersole, Olga
Publicado: (1923)

DNA patents and Diagnostics: Not a Pretty Picture
por: Carbone, Julia, et al.
Publicado: (2010)

Moving beyond Bermuda: sharing data to build a medical information commons
por: Cook-Deegan, Robert, et al.
Publicado: (2017)

Parallels and Mutual Lessons in Tuberculosis and COVID-19 Transmission, Prevention, and Control
por: Hopewell, Philip C., et al.
Publicado: (2021)

Beyond Our Borders? Public Resistance to Global Genomic Data Sharing
por: Majumder, Mary A., et al.
Publicado: (2016)

Governing Heritable Human Genome Editing: A Textual History and a Proposal for the Future
por: Walters, LeRoy, et al.
Publicado: (2021)

Dole effect as a measurement of the low-latitude hydrological cycle over the past 800 ka
por: Huang, Enqing, et al.
Publicado: (2020)

MISSION AND VISION OF THE MULTISITE VA ELIZABETH DOLE CENTER OF EXCELLENCE (EDCOE) FOR VETERAN AND CAREGIVER RESEARCH
por: Trivedi, Ranak
Publicado: (2022)

Multiculturalism is good for flies, too
por: Manak, J. Robert
Publicado: (2018)

Are there any good experiments that should not be done?
por: Pollack, Robert, et al.
Publicado: (2022)

Regarding Combined Pediatric and Adult Trials Submitted to the US Food and Drug Administration 2012–2018
por: Cook, Jack, et al.
Publicado: (2020)

Indian pharmaceutical patent prosecution: The changing role of Section 3(d)
por: Sampat, Bhaven N., et al.
Publicado: (2018)

Good Laboratory Practices and Safety Assessments
por: Becker, Richard A., et al.
Publicado: (2009)

Germany’s digital health reforms in the COVID-19 era: lessons and opportunities for other countries
por: Gerke, Sara, et al.
Publicado: (2020)

Good Laboratory Practices: Becker et al. Respond
por: Becker, Richard A., et al.
Publicado: (2010)

Conservation physiology and the quest for a ‘good’ Anthropocene
por: Madliger, Christine L., et al.
Publicado: (2017)

What's the Use? Disparate Purposes of U.S. Federal Bioethics Commissions
por: Brian, Jenny Dyck, et al.
Publicado: (2017)

The Ban on US Government Funding Research Using Human Fetal Tissues: How Does This Fit with the NIH Mission to Advance Medical Science for the Benefit of the Citizenry?
por: McCune, Joseph M., et al.
Publicado: (2019)

The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak
por: Karch, Helge, et al.
Publicado: (2012)

The good, the bad and the ugly of COVID-19 lockdown effects on wildlife conservation: Insights from the first European locked down country
por: Manenti, Raoul, et al.
Publicado: (2020)

In the name of the greater good?
por: Kirkwood, K
Publicado: (2010)

Evidence-informed policy making at country level: lessons learned from the South African Tuberculosis Think Tank
por: White, R. G., et al.
Publicado: (2018)

Good Laboratory Practices Are Not Synonymous with Good Scientific Practices, Accurate Reporting, or Valid Data
por: vom Saal, Frederick S., et al.
Publicado: (2010)

Perspective: plasticity, the enemy of the good
por: Yvonnet, Sarah, et al.
Publicado: (2019)

Schooling and Covid-19: lessons from recent research on EdTech
por: Fairlie, Robert, et al.
Publicado: (2020)

A Case for Public-Private Partnerships in Health: Lessons From an Honest Broker
por: McKinnon, Robert
Publicado: (2009)

Polysubstance use in the U.S. opioid crisis
por: Compton, Wilson M., et al.
Publicado: (2020)

Good Laboratory Practices: Tyl Responds
por: Tyl, Rochelle W.
Publicado: (2010)

Good enough practices in scientific computing
por: Wilson, Greg, et al.
Publicado: (2017)

Don’t let the perfect be the enemy of the good
por: Munafò, Marcus
Publicado: (2021)

Ten simple rules for good leadership
por: Bourne, Philip E.
Publicado: (2022)

Quiet Lessons
por: Ramsey, Jennifer
Publicado: (2016)

The Role of the Opinion Leader Research Process in Informing Policy Making for Improved Nutrition: Experience and Lessons Learned in Southeast Asia
por: Weissman, Amy, et al.
Publicado: (2020)

University Public-Access Mandates Are Good for Science
por: Shulenburger, David
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_bhn4skvqsnhkn2fsf69obk7bfc